Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Aspirin in Reducing Events in the Elderly
Aspirin in Reducing Events in the Elderly
Status: Enrolling
Updated:  12/31/1969
Wayne State University
1931
mi
from 98109
Detroit, MI
Aspirin in Reducing Events in the Elderly
Aspirin in Reducing Events in the Elderly
Status: Enrolling
Updated: 12/31/1969
Wayne State University
1931
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Aspirin in Reducing Events in the Elderly
Aspirin in Reducing Events in the Elderly
Status: Enrolling
Updated:  12/31/1969
Winthrop University Hospital
2417
mi
from 98109
Mineola, NY
Aspirin in Reducing Events in the Elderly
Aspirin in Reducing Events in the Elderly
Status: Enrolling
Updated: 12/31/1969
Winthrop University Hospital
2417
mi
from 98109
Mineola, NY
Click here to add this to my saved trials
Aspirin in Reducing Events in the Elderly
Aspirin in Reducing Events in the Elderly
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System
1931
mi
from 98109
Detroit, MI
Aspirin in Reducing Events in the Elderly
Aspirin in Reducing Events in the Elderly
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
1931
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Aspirin in Reducing Events in the Elderly
Aspirin in Reducing Events in the Elderly
Status: Enrolling
Updated:  12/31/1969
University of Florida Department of Aging and Geriatrics
2452
mi
from 98109
Gainesville, FL
Aspirin in Reducing Events in the Elderly
Aspirin in Reducing Events in the Elderly
Status: Enrolling
Updated: 12/31/1969
University of Florida Department of Aging and Geriatrics
2452
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
Aspirin in Reducing Events in the Elderly
Aspirin in Reducing Events in the Elderly
Status: Enrolling
Updated:  12/31/1969
Phalen Village Clinic
1401
mi
from 98109
Saint Paul, MN
Aspirin in Reducing Events in the Elderly
Aspirin in Reducing Events in the Elderly
Status: Enrolling
Updated: 12/31/1969
Phalen Village Clinic
1401
mi
from 98109
Saint Paul, MN
Click here to add this to my saved trials
Aspirin in Reducing Events in the Elderly
Aspirin in Reducing Events in the Elderly
Status: Enrolling
Updated:  12/31/1969
Howard University
2322
mi
from 98109
Washington,
Aspirin in Reducing Events in the Elderly
Aspirin in Reducing Events in the Elderly
Status: Enrolling
Updated: 12/31/1969
Howard University
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Central Arkansas Veterans Healthcare System
1779
mi
from 98109
Little Rock, AR
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Central Arkansas Veterans Healthcare System
1779
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
University of California, Davis Medical Center
627
mi
from 98109
Sacramento, CA
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
University of California, Davis Medical Center
627
mi
from 98109
Sacramento, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
University of Miami
2730
mi
from 98109
Miami, FL
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
University of Miami
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Piedmont Hospital
2177
mi
from 98109
Atlanta, GA
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Piedmont Hospital
2177
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Indiana University School of Medicine
1867
mi
from 98109
Indianapolis, IN
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Indiana University School of Medicine
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
1557
mi
from 98109
Iowa City, IA
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
1557
mi
from 98109
Iowa City, IA
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
University of Louisville
1938
mi
from 98109
Louisville, KY
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
University of Louisville
1938
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
2485
mi
from 98109
Boston, MA
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Spectrum Health
1794
mi
from 98109
Grand Rapids, MI
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Spectrum Health
1794
mi
from 98109
Grand Rapids, MI
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Saint Lukes Hospital
1504
mi
from 98109
Kansas City, MO
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Saint Lukes Hospital
1504
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Nebraska-Western Iowa VA Healthcare System
1367
mi
from 98109
Omaha, NE
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Nebraska-Western Iowa VA Healthcare System
1367
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Holy Name Medical Center
2395
mi
from 98109
Teaneck, NJ
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Holy Name Medical Center
2395
mi
from 98109
Teaneck, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Medical College/New York Presbyterian Hospital
2402
mi
from 98109
New York, NY
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical College/New York Presbyterian Hospital
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
2024
mi
from 98109
Cleveland, OH
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Remington Davis Inc.
2008
mi
from 98109
Columbus, OH
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Remington Davis Inc.
2008
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Temple University Hospital
2373
mi
from 98109
Philadelphia, PA
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Temple University Hospital
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
VA Pittsburgh Healthcare System
2131
mi
from 98109
Pittsburgh, PA
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
VA Pittsburgh Healthcare System
2131
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
University of Virginia Hospital
2285
mi
from 98109
Charlottesville, VA
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
University of Virginia Hospital
2285
mi
from 98109
Charlottesville, VA
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Providence Sacred Heart Medical Center
228
mi
from 98109
Spokane, WA
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Providence Sacred Heart Medical Center
228
mi
from 98109
Spokane, WA
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Aurora St. Luke's Medical Center
1687
mi
from 98109
Milwaukee, WI
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Aurora St. Luke's Medical Center
1687
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
UMASS Memorial Health Care
2456
mi
from 98109
Worcester, MA
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
UMASS Memorial Health Care
2456
mi
from 98109
Worcester, MA
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hosp
2438
mi
from 98109
New York, NY
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
2438
mi
from 98109
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
Methodist Hospital
1892
mi
from 98109
Houston, TX
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
Methodist Hospital
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated:  12/31/1969
University Hospitals of Cleveland Medical Center
2020
mi
from 98109
Cleveland, OH
Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)
MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects With Severe Peripheral Arterial Disease (PAD)
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
2020
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Analysis of Cerebral Perfusion Using Head Ultrasound and Multisource Detector Near Infrared Spectroscopy (NIRS) Imaging
Prospective Analysis of Regional Cerebral Perfusion Using Head Ultrasound and Multi-source-detector Near Infrared Spectroscopy (NIRS) Imaging
Status: Enrolling
Updated:  12/31/1969
Children's Medical Center of Dallas
1676
mi
from 98109
Dallas, TX
Analysis of Cerebral Perfusion Using Head Ultrasound and Multisource Detector Near Infrared Spectroscopy (NIRS) Imaging
Prospective Analysis of Regional Cerebral Perfusion Using Head Ultrasound and Multi-source-detector Near Infrared Spectroscopy (NIRS) Imaging
Status: Enrolling
Updated: 12/31/1969
Children's Medical Center of Dallas
1676
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
Stanford Hospital and Outpatient Center
mi
from 98109
Redwood City, CA
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
Stanford Hospital and Outpatient Center
mi
from 98109
Redwood City, CA
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
University of Connecticut Health Center
2424
mi
from 98109
Farmington, CT
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
University of Connecticut Health Center
2424
mi
from 98109
Farmington, CT
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
Georgetown University Hospital
2322
mi
from 98109
Washington,
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
Georgetown University Hospital
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
Arthritis and Rheumatology of Georgia
2174
mi
from 98109
Atlanta, GA
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
Arthritis and Rheumatology of Georgia
2174
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
Rockford Orthopedic Associates, LTD
1656
mi
from 98109
Rockford, IL
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
Rockford Orthopedic Associates, LTD
1656
mi
from 98109
Rockford, IL
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
Diagnostic Rheumatology and Research PC
1868
mi
from 98109
Indianapolis, IN
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
Diagnostic Rheumatology and Research PC
1868
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
Memorial Health System, Inc. dba Memorial Medical Group Clinical Research Institute
mi
from 98109
South Bend, IN
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
Memorial Health System, Inc. dba Memorial Medical Group Clinical Research Institute
mi
from 98109
South Bend, IN
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University Division Of Rheumatology
2328
mi
from 98109
Baltimore, MD
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University Division Of Rheumatology
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
The Center for Rheumatology and Bone Research
2316
mi
from 98109
Wheaton, MD
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
The Center for Rheumatology and Bone Research
2316
mi
from 98109
Wheaton, MD
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology Study Group
2454
mi
from 98109
Worcester, MA
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology Study Group
2454
mi
from 98109
Worcester, MA
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
University of Michigan
1903
mi
from 98109
Ann Arbor, MI
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
University of Michigan
1903
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health System
1903
mi
from 98109
Ann Arbor, MI
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health System
1903
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
West Michigan Rheumatology
1802
mi
from 98109
Grand Rapids, MI
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
West Michigan Rheumatology
1802
mi
from 98109
Grand Rapids, MI
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
Physician Research Collaboration
1346
mi
from 98109
Lincoln, NE
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
Physician Research Collaboration
1346
mi
from 98109
Lincoln, NE
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
UMDNJ - Robert Wood Johnson Medical Center Clinical Research Center
2388
mi
from 98109
New Brunswick, NJ
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
UMDNJ - Robert Wood Johnson Medical Center Clinical Research Center
2388
mi
from 98109
New Brunswick, NJ
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
Center for Rheumatology
2351
mi
from 98109
Albany, NY
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
Center for Rheumatology
2351
mi
from 98109
Albany, NY
Click here to add this to my saved trials
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated:  12/31/1969
Regional Rheumatology Associates
2270
mi
from 98109
Binghamton, NY
PF-00489791 For The Treatment Of Raynaud's
A Phase 2a Randomized Double-blinded, Placebo And Active Controlled Two Cohort Two Doses Cross-over Multi-center Clinical Study To Assess Efficacy Of A Once Daily Administration Of A Phosphodiesterase 5 Inhibitor (Pf-00489791) For The Treatment Of Vasospasm In Primary And Secondary Raynaud's Phenomenon
Status: Enrolling
Updated: 12/31/1969
Regional Rheumatology Associates
2270
mi
from 98109
Binghamton, NY
Click here to add this to my saved trials